SCHEMBL188327

SCHEMBL188327

NCC(=O)Nc1ccccc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LTA4H P09960 2/20 0.64
L3MBTL1 Q9Y468 2/20 0.62
EPHX2 P34913 2/20 0.61
KDM1A O60341 1/20 0.60
MAPT P10636 3/20 0.58
CA1 P00915 2/20 0.58
CA2 P00918 2/20 0.58
HTT P42858 1/20 0.57
CYP3A4 P08684 2/20 0.56
CYP1A2 P05177 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56
TP53 P04637 1/20 0.56
EPHX1 P07099 1/20 0.56
TSHR P16473 1/20 0.56
CDK9 P50750 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
CLK4 Q9HAZ1 1/20 0.56
GAA P10253 1/20 0.55
SCN1A P35498 1/20 0.55

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL11434219 0.98 LTA4H (0.62) LTA4HL3MBTL1EPHX2KDM1AMAPT
Hydrochloric Acid SCHEMBL355185 0.98 LTA4H (0.62) LTA4HL3MBTL1EPHX2KDM1AMAPT
Nitrogen SCHEMBL28401399 0.96 LTA4H (0.60) LTA4HL3MBTL1EPHX2KDM1AMAPT
SCHEMBL11573347 0.86 TERT (0.58) LTA4HL3MBTL1EPHX2KDM1AMAPT
Dimethylformamide SCHEMBL27730038 0.86 LTA4H (0.51) LTA4HL3MBTL1EPHX2KDM1AMAPT
SCHEMBL9001585 0.85 KDM1A (0.59) LTA4HL3MBTL1EPHX2KDM1AMAPT
SCHEMBL11789125 0.85 ALDH1A1 (0.70) LTA4HL3MBTL1MAPTCA1CA2
SCHEMBL11644079 0.85 NPC1 (0.61) LTA4HL3MBTL1MAPTCA1CA2
SCHEMBL399356 0.85 RAB9A (0.69) LTA4HL3MBTL1MAPTCA1CA2
SCHEMBL4400398 0.84 L3MBTL1 (0.71) LTA4HL3MBTL1EPHX2KDM1AMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1413 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115656280-B Preparation method and application of silver-ammonia ion functionalized chitosan compound modified electrode based on carbon nanotube framework 常州大学 2025-05-02 CN claimed
CN-119840206-A Method for producing sheet material, front cover and vehicle 浙江吉利控股集团有限公司 2025-04-18 CN claimed
CN-119264147-A Method for synthesizing C-glycosyl amino acid derivative by chiral auxiliary assisted stereoselective glycosylation 十堰市太和医院(湖北医药学院附属医院) 2025-01-07 CN claimed
US-20240066023-A1 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition SISTEMA UNIVERSITARIO ANA G. MENDEZ, INC. (US) 2024-02-29 US claimed
CN-117482578-A Continuous separation system and method for liquid aniline derivative intermediate 浙江迪邦化工有限公司 2024-02-02 CN claimed
CN-220276722-U Batching cauldron for processing aminoacetoanilide 兰州鼎达科技有限公司 2024-01-02 CN claimed
CN-114539804-B Preparation method of red direct blending dye 浙江闰土染料有限公司 2023-12-15 CN claimed
CN-112225670-B Preparation method of aminoacetoanilide 郑州科旷生物科技有限公司 2023-06-20 CN claimed
CN-115896222-A Enzymatic preparation method of cefalexin 河南康达制药有限公司 2023-04-04 CN claimed
CN-115656280-A Preparation method and application of silver-ammonia ion functionalized chitosan compound modified electrode based on carbon nanotube framework 常州大学 2023-01-31 CN claimed
EP-0017946-A1 Salts of alpha-aminoacetanilides, process for their preparation and their use as plant growth regulators BASF Aktiengesellschaft (DE) 1980-10-29 EP claimed
EP-0015214-A1 Derivatives of substituted 2-benzoyl glycinanilides, their preparation and their use in anxiolytic medicaments PIERRE FABRE S.A. (FR) 1980-09-03 EP claimed
EP-0010030-A1 Derivatives of 2'-(ortho-chloro-benzoyl),4'-chloro-glycin anilide, their preparation and their use in medicines PIERRE FABRE S.A. (FR) 1980-04-16 EP claimed
EP-0002297-A2 Process for the preparation of DL-phenyl-glycine amide STAMICARBON B.V. (NL) 1979-06-13 EP claimed
US-4125730-A Preparation of -aminoalkanoic acid arylamides BANYU PHARMACEUTICAL CO., LTD. (JP) 1978-11-14 US claimed
US-4111980-A Process for preparing optically active phenyl glycine STAMICARBON, B.V. (NL) 1978-09-05 US claimed
US-4094904-A Process of racemizing an optically active phenyl glycine amide with or without a substituted phenyl group STAMICARBON, B.V. (NL) 1978-06-13 US claimed
US-4093653-A RESOLUTION STAMICARBON, B.V. (NL) 1978-06-06 US claimed
US-4080259-A CULTIVATION OF PSEUDOMONAS NOVO INDUSTRI A/S (DK) 1978-03-21 US claimed
US-4036852-A Optical resolution of phenyl-glycine amide STAMICARBON B.V. (NL) 1977-07-19 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240066023-A1 Method for producing benzazoloquinolium (BQs) salts and using the biological activity of the composition AHNAK, RECQL, NBAS LTA4H 3250/4885L3MBTL1 1518/4885EPHX2 2347/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.